92 results
8-K
EX-10.1
MBIO
Mustang Bio Inc
2 May 24
Mustang Bio Announces Pricing of $4 Million Public Offering
4:54pm
Prospectus and Prospectus.
(q) Insurance. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses
S-1/A
EX-10.40
MBIO
Mustang Bio Inc
2 Apr 24
IPO registration (amended)
5:25pm
and Prospectus.
(q) Insurance. The Company and the Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks
S-1
v8ql7te cg2fmer
11 Dec 23
IPO registration
9:52pm
S-1
EX-5.1
7sr32 52d0a67gfeec7m
11 Dec 23
IPO registration
9:52pm
8-K
EX-10.1
s4572
30 Oct 23
Mustang Bio Announces $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
2:57pm
8-K
EX-5.1
ylnppicm
30 Oct 23
Mustang Bio Announces $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
2:57pm
424B5
95mzxi
30 Oct 23
Prospectus supplement for primary offering
10:30am
8-K
EX-10.1
yqa29a
31 Jul 23
Mustang Bio Announces Amendment and Closing of Strategic Manufacturing Partnership Transaction with uBriGene (Boston) Biosciences
8:40am
8-K
EX-10.2
vx77wa
31 Jul 23
Mustang Bio Announces Amendment and Closing of Strategic Manufacturing Partnership Transaction with uBriGene (Boston) Biosciences
8:40am
8-K
EX-1.1
nv2 38ijs
22 May 23
Mustang Bio Announces Strategic Manufacturing Partnership and Portfolio Updates
8:00am
8-K
1dvip7j
22 May 23
Mustang Bio Announces Strategic Manufacturing Partnership and Portfolio Updates
8:00am
8-K
EX-3.2
he15x
3 Apr 23
Mustang Bio Announces Reverse Stock Split
12:48pm